In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Medline Inc (NASDAQ: MDLN) closed the day trading at $40.62 down -3.29% from the previous closing price of $42.0. In other words, the price has decreased by -$3.29 from its previous closing price. On the day, 7.34 million shares were traded. MDLN stock price reached its highest trading level at $42.04 during the session, while it also had its lowest trading level at $40.0.
Ratios:
For a better understanding of MDLN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.67. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.97 whereas as Long-Term Debt/Eq ratio is at 0.96.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 18 ’25 when Hellman & Friedman Capital Par sold 6,088,371 shares for $28.37 per share. The transaction valued at 172,716,735 led to the insider holds 4,806,160 shares of the business.
GIC Private Ltd bought 12,586,206 shares of MDLN for $364,999,974 on Dec 18 ’25. The 10% Owner now owns 27,241,378 shares after completing the transaction at $29.00 per share. On Dec 18 ’25, another insider, GIC Private Ltd, who serves as the 10% Owner of the company, sold 10,204,351 shares for $28.37 each. As a result, the insider received 289,480,090 and left with 91,555,447 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDLN now has a Market Capitalization of 31972732928 and an Enterprise Value of 725690613760. As of this moment, Medline’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.20 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 26.457 whereas that against EBITDA is 223.083.
Stock Price History:
Over the past 52 weeks, MDLN has reached a high of $45.50, while it has fallen to a 52-week low of $34.89. The 50-Day Moving Average of the stock is -3.48%, while the 200-Day Moving Average is calculated to be -3.48%.
Shares Statistics:
Over the past 3-months, MDLN traded about 18.68M shares per day on average, while over the past 10 days, MDLN traded about 11526430 shares per day. A total of 799.80M shares are outstanding, with a floating share count of 792.03M. Insiders hold about 2.39% of the company’s shares, while institutions hold 20.76% stake in the company.
